Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
2 CALLS ON FILE
STLN
— Starling Oncology, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 7, 2026
REVENUE
$147.4M
+3.9%
NET MARGIN
-1.7%
+3.6 PTS
EPS
-$0.02
+66.7%
FREE CASH FLOW
-$3.3M
-249.9%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 2
OLDER CALL →